
大摩下调礼来目标价至 1028 美元
Morgan Stanley has lowered Eli Lilly's target price from $1,135 to $1,028, while maintaining an "Overweight" rating

Morgan Stanley has lowered Eli Lilly's target price from $1,135 to $1,028, while maintaining an "Overweight" rating